Warfarin purple toe

purple toe syndrome. Severe bleeding, unusual pain or swelling, and severe headache require immediate medical attention. The dosage of warfarin

Warfarin anticoagulation is widely used for many clinical indications. Warfarin Evidence of skin necrosis or purple toe syndrome. Pregnancy. Women of

3.1 Hemorrhage ; 3.2 Warfarin necrosis ; 3.3 Osteoporosis ; 3.4 Purple toe syndrome.

Purple toes syndrome: Purple toes syndrome is a complication of warfarin treatment and consists of a dark, purplish or mottled colour of the toes, usually occurring 3 to 10 weeks (or later) after starting treatment with warfarin. Major features of this syndrome include:

by DR Ryu Cited by 5Purple toe syndrome is an extremely rare complication of warfarin therapy. The occurrence of purple toe syndrome is characterized by a sudden appearance of

dc.relation.ispartof, Internal Medicine Journal, en ; dc.title, Purple toes syndrome following stroke thrombolysis and warfarin therapy, en ; dc.

This is the first case report of one of the novel oral anticoagulants being used to treat purple toe syndrome, a case of an 82-year-old man with bilateral blanching vivacious toes and a livedo-reticularis type rash developing 2 weeks after being loaded with warfarin for first detected atrial fibrillation. Purple toe syndrome is a recognised adverse effect of warfarin therapy. The literature

The occurrence of purple toe syndrome may require discontinuation of warfarin. 'Could have been anything - phantom toe syndrome, 'methane build-up, disturbance

Purple toes syndrome is an extremely uncommon, nonhemorrhagic, cutaneous complication associated with warfarin therapy. It is characterized by the sudden appearance of bilateral, painful, purple lesions on the toes and sides of the feet that blanch with pressure. The syndrome usually develops 3 8 weeks after the start of warfarin therapy.